ArticleJournal for immunotherapy of cancer2014

Response assessment in metastatic melanoma treated with ipilimumab and bevacizumab: CT tumor size and density as markers for response and outcome.

Mizuki Nishino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.